2026 Milan CPHI Worldwide Pharmaceutical Ingredients, Machinery & Technology Exhibition, Italy

The 2026 CPHI Worldwide in Milan, Italy (CPHI Worldwide) is one of the largest, longest-running, and most influential comprehensive exhibitions in the global pharmaceutical industry. Since its first edition in 1990, the CPHI series of exhibitions has evolved into a flagship platform connecting the upstream and downstream of the global pharmaceutical supply chain. Annually, CPHI Worldwide rotates among major pharmaceutical hub cities worldwide, and Milan, as a significant economic and industrial center in Europe, hosting CPHI Worldwide further highlights Italy's important position in the European and global pharmaceutical industry. The exhibition not only covers core areas such as pharmaceutical ingredients (APIs), intermediates, and excipients but also extends to various niche segments including pharmaceutical machinery, packaging materials, contract development and manufacturing organizations (CDMO/CMO), biopharmaceuticals, and digital health solutions, forming a complete pharmaceutical ecosystem. The event brings together pharmaceutical companies, R&D institutions, manufacturers, suppliers, purchasers, and industry experts from all over the world, providing them with an excellent opportunity to establish business contacts, explore cutting-edge technologies, understand market trends, and facilitate cooperation and transactions. Its international influence is reflected in the global distribution of exhibitors and visitors, attracting tens of thousands of professionals annually, including senior decision-makers from Fortune 500 pharmaceutical companies. The various specialized conferences, seminars, and forums held during the exhibition are important platforms for industry thought collision and knowledge sharing, guiding the development direction of the global pharmaceutical industry. CPHI Worldwide is not just a trade platform; it is also a barometer for the global pharmaceutical industry, making outstanding contributions to promoting pharmaceutical innovation and the development of global health.

The exhibit range of the 2026 CPHI Worldwide in Milan, Italy, is extremely extensive, covering all aspects of the pharmaceutical industry chain, aiming to provide a one-stop solution for global pharmaceutical professionals. Key exhibit categories and sub-products include: I. Pharmaceutical Ingredients (APIs & Intermediates): Active Pharmaceutical Ingredients (APIs): various chemical synthetic APIs, biotechnological APIs, natural extract APIs, highly potent APIs (HPAPI), cell and gene therapy APIs, etc. Pharmaceutical Intermediates: pharmaceutical intermediates, fine chemical intermediates, chiral intermediates, etc. Excipients: fillers, disintegrants, binders, lubricants, coating materials, solvents, solubilizers, stabilizers, sweeteners, flavors, colorants, etc. Natural Extracts: plant extracts, animal extracts, marine biological extracts, etc., for pharmaceuticals, health products, and functional foods. II. Pharma Machinery & Equipment: Formulation Equipment: tablet presses, capsule filling machines, coating machines, granulators, mixers, dryers, sterilization equipment, filling machines, lyophilizers, etc. Testing & Analytical Instruments: HPLC, GC, mass spectrometers, spectrophotometers, dissolution testers, disintegration testers, hardness testers, microbiological testing equipment, etc. Packaging Equipment & Materials: blister packaging machines, cartoning machines, labeling machines, sealing machines, bottling lines, aluminum-plastic/aluminum-aluminum packaging, glass bottles, plastic bottles, pharmaceutical tubes, labels, anti-counterfeiting packaging materials, etc. Laboratory Equipment: incubators, centrifuges, pure water equipment, laminar flow hoods, biosafety cabinets, etc. Cleanroom Technology & Equipment: air filters, cleanroom systems, laminar flow hoods, cleanroom garments, etc. III. Contract Services: Contract Development and Manufacturing Organizations (CDMO/CMO): API custom synthesis, formulation R&D and manufacturing, clinical trial drug production, biopharmaceutical contract development and manufacturing, etc. Clinical Research Organizations (CRO): preclinical research, clinical trial management, biostatistics, data management, etc. Drug Discovery Services: target validation, lead compound screening and optimization, pharmacokinetics (ADME) studies, etc. IV. BioPharma: Biologics: vaccines, antibodies, recombinant proteins, cell therapy, gene therapy products, etc. Bioprocess Equipment & Consumables: bioreactors, fermenters, chromatography systems, ultrafiltration systems, single-use technologies, culture media, buffers, etc. Bioanalysis & Testing: bioactivity assays, immunoassays, molecular diagnostics, etc. V. Digital Health & Technology: Pharmaceutical IT Solutions: ERP systems, MES systems, LIMS systems, QMS systems, data management and analysis, artificial intelligence and machine learning applications, etc. Traceability Systems & Anti-counterfeiting Technologies: drug traceability, serialization, blockchain technology applications in pharmaceuticals. Smart Manufacturing & Automation: industrial robots, automated production lines, Internet of Things (IoT) applications. VI. Other Related Services: Quality control and regulatory consulting, intellectual property services, project management, supply chain management, logistics services, investment and financing, etc.

No fee information available. Please contact us for a quote.